CEO of Pfizer, Dr Albert Bourla, to address Greek Australians during online event

·

The Hellenic Initiative Australia (THI Australia) is holding a ‘In Conversation’ event with Dr Albert Bourla, Chairman and Chief Executive Officer of Pfizer, a global business leader and an outstanding member of the Greek diaspora.

The event will be held on Monday, 8 November 2021 (USA and Canada) at 6.30pm EST and Tuesday, 9 November 2021 (Australia) at 10.30am Australian Eastern Standard Time (AEST).

Dr Bourla will be joined by Andrew N Liveris AO during the conversation.

In this milestone year for Greece, marking 200 years since the commencement of the Greek War of Independence, THI Australia is honoured to host such an event with two exceptional members of the Greek diaspora, who continue to support and promote Greece.

THI Australia is a not-for-profit organisation and part of a global movement, bringing together the Greek diaspora and Philhellenes in support of Greece and its people. A registered charity with DGR status, all donations are tax deductible in Australia.

To attend the event, registration is essential so you can receive a unique zoom link to log in to the webinar.

READ MORE: Greek CEO of Pfizer says COVID-19 vaccine is more than 90% effective.

About the Speakers:

DR ALBERT BOURLA, DVM, PH.D. Chairman and Chief Executive Officer, Pfizer

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding a number of senior global positions across a range of markets and disciplines. Prior to taking the reins as CEO in January 2019, Albert served as the Pfizer’s Chief Operating Officer (COO) beginning in January 2018, responsible for overseeing the Company’s commercial strategy, manufacturing, and global product development functions.

Dr Albert Bourla.

Previously, from February 2016 to December 2017, Albert served as Group President of Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups.

READ MORE: Pfizer’s Greek CEO, Albert Bourla, says third Covid vaccine dose likely needed within 12 months.

In addition, he created the Patient and Health Impact Group, dedicated to developing solutions for increasing patient access, demonstrating the value of Pfizer’s medicines, and ensuring broader business model innovation.

From January 2014 to January 2016, Albert served as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanding the Company’s leadership in Vaccines.

Albert was President and General Manager of Pfizer’s Established Products business from 2010- 2013, leading the development and implementation of strategies and tactics related to Pfizer’s offpatent portfolio, (including legacy brands and generics).

Dr Bourla is the CEO of Pfizer.

He began his Pfizer career in 1993 in the Animal Health Division as Technical Director of Greece. He held positions of increasing responsibility within Animal Health across Europe, before moving to Pfizer’s New York Global Headquarters in 2001.

From there, Albert went on to assume a succession of leadership roles within the Animal Health Division, including US Group Marketing Director (2001-2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, he assumed additional responsibilities for the Asia and Pacific regions.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2020, he was ranked as America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine.

He is on the executive committee of The Partnership for New York City, a vice president of the International Federation of Pharmaceutical Manufacturers & Associations, a director on multiple boards – Pfizer, Inc., The Pfizer Foundation, PhRMA, and Catalyst – and a Trustee of the United States Council for International Business. In addition, Albert is a member of the Business Roundtable and the Business Council.

READ MORE: Pfizer opens hubs in Thessaloniki.

ANDREW N LIVERIS AO:

Andrew is the former Chairman and CEO of the Dow Chemical Company and former Executive Chairman of Dow DuPont.

Andrew Liveris AO.

Andrew was the Special Advisor to the Australian National COVID-19 Coordination Commission. He is Co-Chair of the Northern Territory Economic Reconstruction Commission, advising on how to accelerate the Territory’s economic rebound and growth. He is an Independent Member of the Australian Government’s Industry Growth Centres Advisory Committee.

Andrew is a Director at IBM, Saudi Aramco, Worley (Deputy Chairman), Lucid Motors (Chairman), NOVONIX and the Minderoo Foundation. He is on the advisory board of Sumitomo Mitsui Banking Corporation, Teneo (a global CEO consulting and advisory firm), and NEOM (an initiative driven by Saudi Vision 2030).

He is Chairman of the BlackRock Long Term Private Capital Fund and a Special Advisor to the Public Investment Fund (PIF) and the Crown Prince of Saudi Arabia. Andrew also serves as a Trustee for the King Abdullah University of Science and Technology (KAUST) and is a member of the Concordia Leadership Council.

In 2018, the Andrew N Liveris Academy for Innovation and Leadership was established at the University of Queensland for students to garner a real-life understanding of the global challenges and how to create positive change for society.

Advertisement

Share:

KEEP UP TO DATE WITH TGH

By subscribing you accept our Terms of Service and Privacy Policy.

Advertisement

Latest News

Peter Tsegas quits embattled Magnis Energy as Tanzanian mine project faces scrutiny

Peter Tsegas, a long-serving director of Magnis Energy Technologies, has stepped down from the company amid deepening financial troubles.

Angelos Angelopoulos loses appeal over funeral funding discrimination claim

Angelos Angelopoulos has lost his legal battle against the Queensland Government over claims of religious discrimination.

Maria Charalambous saves husband from Sydney house fire

Maria Charalambous is being hailed a hero after saving her husband, from a devastating house fire that destroyed their Bonnyrigg Heights home.

Ecumenical Patriarch Bartholomew meets Pope Leo XIV a second time

Ecumenical Patriarch Bartholomew met with Pope Leo XIV for the second time at the Apostolic Palace in the Vatican.

South Melbourne storm to fourth win of season in emphatic style

South Melbourne FC was spectacular against Melbourne Victory Youth on Sunday, winning 4-2 and celebrating their second consecutive win.

You May Also Like

Victorian Premier extends invitation to Greek PM for 2025 visit

Premier of Victoria, Jacinta Allan expressed the significance of having the Greek PM visit Melbourne, the third-largest Greek city globally.

Village mentality: What Greek and Indian traditions teach us about caring for the elderly

An exploration of how cultures like Greek and Indian traditions honour and care for their elderly with respect, connection, and community.

BREAKING: NSW Premier announces new Sydney restrictions

NSW has reintroduced social distancing measures after recording 16 new locally acquired COVID-19 cases, bringing the Bondi cluster to 31.